Welcome to our dedicated page for DFSCW news (Ticker: DFSCW), a resource for investors and traders seeking the latest updates and insights on DFSCW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DFSCW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DFSCW's position in the market.
DEFSEC Technologies (TSXV:DFSC, NASDAQ:DFSC) announced on Dec 5, 2025 that it will staff a total of 39 roles for government services commencing February 2026, up 62.5% from 24 roles previously disclosed. Effective February 2026, DEFSEC's go-forward annualized program billings are expected to rise to approximately CAD$8.3M (from CAD$5.1M previously reported) and to be ~704% higher than FY2024 programmatic revenue of CAD$1.0M. Annualized gross margin contribution on programmatic work is expected to reach ~CAD$2.3M (an ~845% increase versus FY2024).
The company will subcontract 13 of 15 new roles from ADGA and says commencement is subject to customary onboarding procedures.
